General MedicationsTOPICALGeneric

KENALOG

TRIAMCINOLONE ACETONIDE

Standard Dose

0.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Max Dose

Refer to approved labeling

Primary Use

Marketing status: Discontinued

Summary

Approval overview KENALOG is listed in Drugs@FDA under application 083944 (ANDA).

Marketing status: Discontinued Active ingredient TRIAMCINOLONE ACETONIDE Form and strength OINTMENT;TOPICAL - 0.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor DELCOR ASSET CORP Submission history Latest submission status date: 1974-01-29 00:00:00.

Structured Monograph

Clinical summary

Approval overview KENALOG is listed in Drugs@FDA under application 083944 (ANDA). Marketing status: Discontinued Active ingredient TRIAMCINOLONE ACETONIDE Form and strength OINTMENT;TOPICAL - 0.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor DELCOR ASSET CORP Submission history Latest submission status date: 1974-01-29 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: Discontinued

Interaction Notes

No interaction notes stored yet.